Content about Investment banks

April 8, 2013
Safeway hoping to raise as much as $220 million through Blackhawk IPO

Blackhawk Network Holdings announced its intent to open its initial public offering of 10 million shares at an estimated offering price of $20 to $22 per share.

March 20, 2013
Sagent appoints James Hussey as president

Generic drug maker Sagent Pharmaceuticals has appointed James Hussey as its president, the company said.

February 15, 2013
Vitamin Shoppe closes deal on 31-store acquisition in Northwest

The Vitamin Shoppe announced that it has closed on the previously announced purchase of Super Supplements — a specialty retailer of vitamins, minerals and supplements — for approximately $50 million.

December 12, 2012
Markwins closes acquisition of Physicians Formula

Markwins announced on Wednesday that it has acquired all of the outstanding securities of Physicians Formula for $75 million or $4.90 per share in cash.

September 11, 2012
Walgreens announces pricing of senior notes

Walgreens on Monday announced that it has priced an underwritten public offering of senior notes.

March 14, 2012
A&P emerges from Chapter 11

Grocer A&P has emerged from bankruptcy as a privately held company.

January 3, 2012
Credit Suisse: December drug channel comps will be lackluster

Retailers will report weak December front-end sales growth across the drug channel as continued inflation likely was offset by the slow start to the flu season and disappointing overall traffic and volume growth, Credit Suisse research analyst Ed Kelly suggested in a note published Tuesday.

August 30, 2011
Sagent names new CFO

Jonathon Singer has been appointed CFO of Sagent Pharmaceuticals, the generic drug maker said.

April 1, 2011
GNC announces IPO

GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

March 21, 2011
Credit Suisse projects strong Q2 for WAG

Following the recent sale of Walgreens' pharmacy benefit management business, Credit Suisse analysts said they are interested in the executive team's updated thinking on their healthcare strategy and plans for the $550 million in proceeds.

October 5, 2010
Sagent's injectable antibiotics enter market

Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday....

May 9, 2010
Actavis, Sagent partner to develop and market injectable drugs

Actavis and Sagent Pharmaceuticals have agreed to develop and market a group of injectable drugs...

© 2013 Drug Store News. All Rights Reserved.